Sponsor pipeline

AbelZeta Inc. clinical trial pipeline

Get alerts when AbelZeta Inc.'s trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-20

What changed in the last 30 days

First postedNew trial filingPhaseStatus
2026-10-15 NCT07875413 Prizloncabtagene Autoleucel (Prizlon-cel) for the Treatment of Relapsed or Refractory… Phase 2 Not Yet Recruiting
2026-10-02 NCT07854483 C-CAR168, an Autologous Anti-CD20/BCMA Chimeric Antigen Receptor T-Cell Therapy, in… Phase 1 Not Yet Recruiting

Active trials by phase

Phase 1
1
Phase 1/2
1
Phase 2
2

Disease areas by active trials

DLBCL (1) · Follicular Lymphoma (1) · Lupus (SLE) (1) · Multiple Sclerosis (1) · Non-Hodgkin Lymphoma (1) · Scleroderma (1)

Get alerts when AbelZeta Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free